Type II hypersensitivity
| Type II hypersensitivity | |
|---|---|
| Synonyms | Cytotoxic hypersensitivity |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hemolytic anemia, thrombocytopenia, Goodpasture syndrome, Graves' disease |
| Complications | Tissue damage, organ failure |
| Onset | Variable, depending on the specific condition |
| Duration | Chronic or acute, depending on the specific condition |
| Types | N/A |
| Causes | Autoimmune reaction, blood transfusion reactions, drug-induced reactions |
| Risks | Genetic predisposition, previous exposure to antigens |
| Diagnosis | Coombs test, immunofluorescence |
| Differential diagnosis | Type I hypersensitivity, Type III hypersensitivity, Type IV hypersensitivity |
| Prevention | Avoidance of known triggers, careful blood matching |
| Treatment | Corticosteroids, immunosuppressive drugs, plasmapheresis |
| Medication | N/A |
| Prognosis | Variable, depending on the specific condition and treatment |
| Frequency | Rare, varies with specific conditions |
| Deaths | N/A |
Type II hypersensitivity is a type of immune response in which the body's immune system causes damage to its own cells. It is one of the four types of hypersensitivity reactions, and is also known as cytotoxic hypersensitivity.
Mechanism[edit]
Type II hypersensitivity occurs when antibodies produced by the immune system bind to antigens on the body's own cells, marking them for destruction. This can result in conditions such as autoimmune diseases, in which the body's immune system attacks its own tissues. The antibodies involved in type II hypersensitivity are usually of the IgG and IgM classes. They bind to antigens on the surface of cells, leading to one of three harmful effects:
- Opsonization and phagocytosis of cells
- Inflammation
- Cell dysfunction
Diseases associated with Type II hypersensitivity[edit]
Several diseases and conditions are associated with type II hypersensitivity, including:
- Autoimmune hemolytic anemia
- Goodpasture syndrome
- Pemphigus vulgaris
- Rheumatic fever
- Graves' disease
- Myasthenia gravis
Diagnosis[edit]
Diagnosis of type II hypersensitivity involves identifying the presence of antibodies against the body's own cells. This can be done through various laboratory tests, such as Direct Coombs test and Indirect Coombs test.
Treatment[edit]
Treatment for type II hypersensitivity involves managing the underlying condition causing the reaction. This can involve immunosuppressive drugs, plasmapheresis, or intravenous immunoglobulin therapy.
See also[edit]
- Type I hypersensitivity
- Type III hypersensitivity
- Type IV hypersensitivity
- Autoimmune disease
- Immunology
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
